Serveur d'exploration sur le Covid à Stanford

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Survey of Telehealth Adoption by Neuro-ophthalmologists During the COVID-19 Pandemic: Benefits, Barriers, and Utility.

Identifieur interne : 000256 ( Main/Exploration ); précédent : 000255; suivant : 000257

Survey of Telehealth Adoption by Neuro-ophthalmologists During the COVID-19 Pandemic: Benefits, Barriers, and Utility.

Auteurs : Heather E. Moss [États-Unis] ; Kevin E. Lai ; Melissa W. Ko

Source :

RBID : pubmed:32639269

Descripteurs français

English descriptors

Abstract

BACKGROUND

During the COVID-19 pandemic, telehealth modalities have come to prominence as a strategy for providing patient care when in-person care provision opportunities are limited. The degree of adoption by neuro-ophthalmologists has not been quantified.

METHODS

Telehealth utilization pre-COVID-19 and peri-COVID-19 was surveyed among practicing neuro-ophthalmologists in and outside the United States using an online platform. Demographics, perceived benefits, barriers, and utility for different neuro-ophthalmic conditions were collected. Data collection occurred over a 2-week period in May 2020.

RESULTS

Two hundred eight practicing neuro-ophthalmologists (81.3% United States, 50.2% females, age range <35 to >65, mode 35-44 years) participated in the survey. Utilization of all telehealth modalities increased from pre-COVID to peri-COVID (video visit 3.9%-68.3%, P < 0.0005, remote interpretation of testing 26.7%-32.2%, P = 0.09, online second opinion 7.9%-15.3%, P = 0.001, and interprofessional e-consult 4.4%-18.7%, P < 0.0005, McNemar). The majority selected access, continuity, and patient efficiency of care as benefits and data quality as a barrier. Telehealth was felt to be most helpful for conditions relying on history, external examination, and previously collected ancillary testing and not helpful for conditions requiring funduscopic examination.

CONCLUSIONS

Telehealth modality usage by neuro-ophthalmologists increased during the COVID-19 pandemic. Identified benefits have relevance both during and beyond COVID-19. Further work is needed to address barriers in their current and future states to maintain these modalities as viable care delivery options.


DOI: 10.1097/WNO.0000000000001051
PubMed: 32639269
PubMed Central: PMC7382419


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Survey of Telehealth Adoption by Neuro-ophthalmologists During the COVID-19 Pandemic: Benefits, Barriers, and Utility.</title>
<author>
<name sortKey="Moss, Heather E" sort="Moss, Heather E" uniqKey="Moss H" first="Heather E" last="Moss">Heather E. Moss</name>
<affiliation wicri:level="2">
<nlm:affiliation>Departments of Ophthalmology (HEM) and Neurology & Neurological Sciences (HEM), Stanford University, Palo Alto, California; Department of Ophthalmology (KEL, MWK), Indiana University School of Medicine, Indianapolis, Indiana; Ophthalmology Service (KEL), Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana; and Departments of Neurology and Neurosurgery (MWK), Indiana University School of Medicine, Indianapolis, Indiana.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Indiana</region>
</placeName>
<wicri:cityArea>Departments of Ophthalmology (HEM) and Neurology & Neurological Sciences (HEM), Stanford University, Palo Alto, California; Department of Ophthalmology (KEL, MWK), Indiana University School of Medicine, Indianapolis, Indiana; Ophthalmology Service (KEL), Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana; and Departments of Neurology and Neurosurgery (MWK), Indiana University School of Medicine, Indianapolis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Lai, Kevin E" sort="Lai, Kevin E" uniqKey="Lai K" first="Kevin E" last="Lai">Kevin E. Lai</name>
</author>
<author>
<name sortKey="Ko, Melissa W" sort="Ko, Melissa W" uniqKey="Ko M" first="Melissa W" last="Ko">Melissa W. Ko</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32639269</idno>
<idno type="pmid">32639269</idno>
<idno type="doi">10.1097/WNO.0000000000001051</idno>
<idno type="pmc">PMC7382419</idno>
<idno type="wicri:Area/Main/Corpus">000527</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000527</idno>
<idno type="wicri:Area/Main/Curation">000527</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000527</idno>
<idno type="wicri:Area/Main/Exploration">000527</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Survey of Telehealth Adoption by Neuro-ophthalmologists During the COVID-19 Pandemic: Benefits, Barriers, and Utility.</title>
<author>
<name sortKey="Moss, Heather E" sort="Moss, Heather E" uniqKey="Moss H" first="Heather E" last="Moss">Heather E. Moss</name>
<affiliation wicri:level="2">
<nlm:affiliation>Departments of Ophthalmology (HEM) and Neurology & Neurological Sciences (HEM), Stanford University, Palo Alto, California; Department of Ophthalmology (KEL, MWK), Indiana University School of Medicine, Indianapolis, Indiana; Ophthalmology Service (KEL), Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana; and Departments of Neurology and Neurosurgery (MWK), Indiana University School of Medicine, Indianapolis, Indiana.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Indiana</region>
</placeName>
<wicri:cityArea>Departments of Ophthalmology (HEM) and Neurology & Neurological Sciences (HEM), Stanford University, Palo Alto, California; Department of Ophthalmology (KEL, MWK), Indiana University School of Medicine, Indianapolis, Indiana; Ophthalmology Service (KEL), Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana; and Departments of Neurology and Neurosurgery (MWK), Indiana University School of Medicine, Indianapolis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Lai, Kevin E" sort="Lai, Kevin E" uniqKey="Lai K" first="Kevin E" last="Lai">Kevin E. Lai</name>
</author>
<author>
<name sortKey="Ko, Melissa W" sort="Ko, Melissa W" uniqKey="Ko M" first="Melissa W" last="Ko">Melissa W. Ko</name>
</author>
</analytic>
<series>
<title level="j">Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society</title>
<idno type="eISSN">1536-5166</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Attitude of Health Personnel (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Delivery of Health Care (organization & administration)</term>
<term>Facilities and Services Utilization (organization & administration)</term>
<term>Female (MeSH)</term>
<term>Health Care Surveys (MeSH)</term>
<term>Health Services Accessibility (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Neurologists (statistics & numerical data)</term>
<term>Ophthalmologists (statistics & numerical data)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Telemedicine (organization & administration)</term>
<term>United States (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Accessibilité des services de santé (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Attitude du personnel soignant (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Enquêtes sur les soins de santé (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Mâle (MeSH)</term>
<term>Neurologues (statistiques et données numériques)</term>
<term>Ophtalmologistes (statistiques et données numériques)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Prestations des soins de santé (organisation et administration)</term>
<term>Sujet âgé (MeSH)</term>
<term>Télémédecine (organisation et administration)</term>
<term>Utilisation des installations et des services (organisation et administration)</term>
<term>États-Unis (épidémiologie)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr">
<term>Prestations des soins de santé</term>
<term>Télémédecine</term>
<term>Utilisation des installations et des services</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en">
<term>Delivery of Health Care</term>
<term>Facilities and Services Utilization</term>
<term>Telemedicine</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en">
<term>Neurologists</term>
<term>Ophthalmologists</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr">
<term>Neurologues</term>
<term>Ophtalmologistes</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>États-Unis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Attitude of Health Personnel</term>
<term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Female</term>
<term>Health Care Surveys</term>
<term>Health Services Accessibility</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Accessibilité des services de santé</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Attitude du personnel soignant</term>
<term>Betacoronavirus</term>
<term>Enquêtes sur les soins de santé</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Sujet âgé</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>États-Unis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>During the COVID-19 pandemic, telehealth modalities have come to prominence as a strategy for providing patient care when in-person care provision opportunities are limited. The degree of adoption by neuro-ophthalmologists has not been quantified.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>Telehealth utilization pre-COVID-19 and peri-COVID-19 was surveyed among practicing neuro-ophthalmologists in and outside the United States using an online platform. Demographics, perceived benefits, barriers, and utility for different neuro-ophthalmic conditions were collected. Data collection occurred over a 2-week period in May 2020.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>Two hundred eight practicing neuro-ophthalmologists (81.3% United States, 50.2% females, age range <35 to >65, mode 35-44 years) participated in the survey. Utilization of all telehealth modalities increased from pre-COVID to peri-COVID (video visit 3.9%-68.3%, P < 0.0005, remote interpretation of testing 26.7%-32.2%, P = 0.09, online second opinion 7.9%-15.3%, P = 0.001, and interprofessional e-consult 4.4%-18.7%, P < 0.0005, McNemar). The majority selected access, continuity, and patient efficiency of care as benefits and data quality as a barrier. Telehealth was felt to be most helpful for conditions relying on history, external examination, and previously collected ancillary testing and not helpful for conditions requiring funduscopic examination.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSIONS</b>
</p>
<p>Telehealth modality usage by neuro-ophthalmologists increased during the COVID-19 pandemic. Identified benefits have relevance both during and beyond COVID-19. Further work is needed to address barriers in their current and future states to maintain these modalities as viable care delivery options.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32639269</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>08</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2021</Year>
<Month>01</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1536-5166</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>40</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2020</Year>
<Month>09</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society</Title>
<ISOAbbreviation>J Neuroophthalmol</ISOAbbreviation>
</Journal>
<ArticleTitle>Survey of Telehealth Adoption by Neuro-ophthalmologists During the COVID-19 Pandemic: Benefits, Barriers, and Utility.</ArticleTitle>
<Pagination>
<MedlinePgn>346-355</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/WNO.0000000000001051</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND">During the COVID-19 pandemic, telehealth modalities have come to prominence as a strategy for providing patient care when in-person care provision opportunities are limited. The degree of adoption by neuro-ophthalmologists has not been quantified.</AbstractText>
<AbstractText Label="METHODS">Telehealth utilization pre-COVID-19 and peri-COVID-19 was surveyed among practicing neuro-ophthalmologists in and outside the United States using an online platform. Demographics, perceived benefits, barriers, and utility for different neuro-ophthalmic conditions were collected. Data collection occurred over a 2-week period in May 2020.</AbstractText>
<AbstractText Label="RESULTS">Two hundred eight practicing neuro-ophthalmologists (81.3% United States, 50.2% females, age range <35 to >65, mode 35-44 years) participated in the survey. Utilization of all telehealth modalities increased from pre-COVID to peri-COVID (video visit 3.9%-68.3%, P < 0.0005, remote interpretation of testing 26.7%-32.2%, P = 0.09, online second opinion 7.9%-15.3%, P = 0.001, and interprofessional e-consult 4.4%-18.7%, P < 0.0005, McNemar). The majority selected access, continuity, and patient efficiency of care as benefits and data quality as a barrier. Telehealth was felt to be most helpful for conditions relying on history, external examination, and previously collected ancillary testing and not helpful for conditions requiring funduscopic examination.</AbstractText>
<AbstractText Label="CONCLUSIONS">Telehealth modality usage by neuro-ophthalmologists increased during the COVID-19 pandemic. Identified benefits have relevance both during and beyond COVID-19. Further work is needed to address barriers in their current and future states to maintain these modalities as viable care delivery options.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Moss</LastName>
<ForeName>Heather E</ForeName>
<Initials>HE</Initials>
<AffiliationInfo>
<Affiliation>Departments of Ophthalmology (HEM) and Neurology & Neurological Sciences (HEM), Stanford University, Palo Alto, California; Department of Ophthalmology (KEL, MWK), Indiana University School of Medicine, Indianapolis, Indiana; Ophthalmology Service (KEL), Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana; and Departments of Neurology and Neurosurgery (MWK), Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lai</LastName>
<ForeName>Kevin E</ForeName>
<Initials>KE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ko</LastName>
<ForeName>Melissa W</ForeName>
<Initials>MW</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 EY026877</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neuroophthalmol</MedlineTA>
<NlmUniqueID>9431308</NlmUniqueID>
<ISSNLinking>1070-8022</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001291" MajorTopicYN="N">Attitude of Health Personnel</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000078336" MajorTopicYN="N">Facilities and Services Utilization</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000072141" MajorTopicYN="N">Neurologists</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000072163" MajorTopicYN="N">Ophthalmologists</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017216" MajorTopicYN="N">Telemedicine</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>7</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>8</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>7</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32639269</ArticleId>
<ArticleId IdType="doi">10.1097/WNO.0000000000001051</ArticleId>
<ArticleId IdType="pmc">PMC7382419</ArticleId>
<ArticleId IdType="pii">00041327-202009000-00010</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Mann DM, Chen J, Chunara R, Testa PA, Nov O. COVID-19 transforms health care through telemedicine: evidence from the field. J Am Med Inform Assoc. 2020;ocaa072 (epub ahead of print).</Citation>
</Reference>
<Reference>
<Citation>Wosik J, Fudim M, Cameron B, Gellad ZF, Cho A, Phinney D, Curtis S, Roman M, Poon EG, Ferranti J, Katz JN, Tcheng J. Telehealth transformation: COVID-19 and the rise of virtual care. J Am Med Inform Assoc. 2020;27:957–962.</Citation>
</Reference>
<Reference>
<Citation>Grossman SN, Calix R, Tow S, Odel JG, Sun LD, Balcer LJ, Galetta SL, Rucker JC. Neuro-ophthalmology in the era of COVID-19: future implications of a public health crisis. Ophthalmology. 2020;S0161-6420(20)30429-2.</Citation>
</Reference>
<Reference>
<Citation>Bruce B, Subramanian P, Ko MW, Chiang M. Telemedicine for Neuro-Ophthalmology. Neuro-ophthalmology Virtual Education Library, 2013:387–419. North American Neuro-Ophthalmology Society 39th Annual Meeting; February 14, 2013; Snowbird Ski Resort, Snowbird, UT. Available at: https://novel.utah.edu/collection/NAM/program/20130214_nanos_telemedicinesympos/year/2013/.</Citation>
</Reference>
<Reference>
<Citation>Ko MW, Lai K, Zimmer-Galler IE, Gold DR, Moss HE. Telemedicine and Neuro-Ophthalmology: 20/20 in 2020. North American Virtual Education Library, 2020:259–284. North American Neuro-Ophthalmology Society 46th Annual Meeting; March 9, 2020; Omni Amelia Island Plantation Resort, Amelia Island, FL. Available at: https://novel.utah.edu/collection/NAM/program/20200309_nanos_telemedicine_1/year/2020/.</Citation>
</Reference>
<Reference>
<Citation>Lai KE, Ko MW, Rucker JC, Odel JG, Sun LD, Winges KM, Ghosh A, Bindiganavile SH, Bhat N, Wendt S, Scharf J, Dinkin MJ, Rasool N, Galetta SL, Lee AG. Tele-Neuro-Ophthalmology during the age of COVID-19. J Neuroophthalmol. 2020. doi: 10.1097/WNO.0000000000001024.</Citation>
<ArticleIdList>
<ArticleId IdType="doi">10.1097/WNO.0000000000001024</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Friedman DI, Rajan B, Seidmann A. A randomized trial of telemedicine for migraine management. Cephalalgia. 2019;39:1577–1585.</Citation>
</Reference>
<Reference>
<Citation>Bruce BB. Nonmydriatic ocular fundus photography in the emergency department: how it can benefit neurologists. Semin Neurol. 2015;35:491–495.</Citation>
</Reference>
<Reference>
<Citation>VI L, JA L. Visual Fields with Interpretation Only—a Preliminary Evaluation. Neuro-ophthalmology Virtual Education Library, 2014:370. North American Neuro-Ophthalmology Society 40th Annual Meeting; March 4, 2014; Rio Grande, Puerto Rico. Available at: https://collections.lib.utah.edu/ark:/87278/s6sx9kzz.</Citation>
</Reference>
<Reference>
<Citation>Telehealth Index: 2019 Consumer Survey. 2020. Available at: https://static.americanwell.com/app/uploads/2019/07/American-Well-Telehealth-Index-2019-Consumer-Survey-eBook2.pdf. Accessed May 8, 2020.</Citation>
</Reference>
<Reference>
<Citation>Wechsler LR. Advantages and limitations of teleneurology. JAMA Neurol. 2015;72:349–354.</Citation>
</Reference>
<Reference>
<Citation>Rathi S, Tsui E, Mehta N, Zahid S, Schuman JS. The current state of teleophthalmology in the United States. Ophthalmology. 2017;124:1729–1734.</Citation>
</Reference>
<Reference>
<Citation>Public Readiness and Emergency Preparedness Act. 2020. Available at: phe.gov/Preparedness/legal/prepact/Pages/deault.aspx. Acccessed May 26, 2020.</Citation>
</Reference>
<Reference>
<Citation>Liability Protections for Health Care Professionals During COVID-19. 2020. Available at: https://www.ama-assn.org/practice-management/sustainability/liability-protections-health-care-professionals-during-covid-19. Accessed May 20, 2020.</Citation>
</Reference>
<Reference>
<Citation>Medicare Telehealth Frequently Asked Questions (FAQs). 2020. Available at: https://edit.cms.gov/files/document/medicare-telehealth-frequently-asked-questions-faqs-31720.pdf. Accessed April 14, 2020.</Citation>
</Reference>
<Reference>
<Citation>Afshari M, Witek NP, Galifianakis NB. Education Research: an experiential outpatient teleneurology curriculum for residents. Neurology. 2019;93:170–175.</Citation>
</Reference>
<Reference>
<Citation>Draugalis JR, Coons SJ, Plaza CM. Best practices for survey research reports: a synopsis for authors and reviewers. Am J Pharm Educ. 2008;72:11.</Citation>
</Reference>
<Reference>
<Citation>Saleem SM, Pasquale LR, Sidoti PA, Tsai JC. Virtual ophthalmology: telemedicine in a covid-19 era. Am J Ophthalmol. 2020;S0002-9394(20)30214-2.</Citation>
</Reference>
<Reference>
<Citation>Baum S. Can a virtual specialist consult program help hospitals break down geographic barriers. MedCity News. 2015. Available at: https://medcitynews.com/2015/11/virtual-specialist-consults/. Accessed July 3, 2020.</Citation>
</Reference>
<Reference>
<Citation>Reddy S. New ways for patients to get a second opinion: online services from established medical centers and independent businesses. Wall Street J. 2015:2015. Available at: wjs.com/articles/new-ways-to-get-a-second-opinion-1440437584. Accessed July 5, 2020.</Citation>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Indiana</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Ko, Melissa W" sort="Ko, Melissa W" uniqKey="Ko M" first="Melissa W" last="Ko">Melissa W. Ko</name>
<name sortKey="Lai, Kevin E" sort="Lai, Kevin E" uniqKey="Lai K" first="Kevin E" last="Lai">Kevin E. Lai</name>
</noCountry>
<country name="États-Unis">
<region name="Indiana">
<name sortKey="Moss, Heather E" sort="Moss, Heather E" uniqKey="Moss H" first="Heather E" last="Moss">Heather E. Moss</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidStanfordV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000256 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000256 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidStanfordV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32639269
   |texte=   Survey of Telehealth Adoption by Neuro-ophthalmologists During the COVID-19 Pandemic: Benefits, Barriers, and Utility.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32639269" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidStanfordV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Tue Feb 2 21:24:25 2021. Site generation: Tue Feb 2 21:26:08 2021